Zheng Quan Zhi Xing·2025-08-04 16:22Group 1 - The report indicates that there were no changes in the issued shares for both H-shares and A-shares of Kailaiying Pharmaceutical Group (Tianjin) Co., Ltd. as of July 31, 2025 [1][2] - The total issued share capital remains at RMB 360,593,720, with 27,553,260 H-shares and 333,040,460 A-shares unchanged from the previous month [1][2] - The report confirms that there were no new shares issued or treasury shares transferred during the month [1][2] Group 2 - The report specifies that there are no applicable details regarding stock options, warrants, or convertible bonds for the company [1][2] - There were no changes in treasury shares for both H-shares and A-shares, with the total remaining at 0 for the month [2] - The report does not include any information related to Hong Kong depositary receipts [2][3]